Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.130
-0.020 (-1.74%)
Apr 29, 2026, 1:17 PM EDT - Market open
Inovio Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 93 | 120 | 66 | 139 | 389 | 1,050 | |
| Market Cap Growth | 59.91% | 80.95% | -52.55% | -64.23% | -62.93% | -29.98% | |
| Enterprise Value | 44 | 79 | -6 | 2 | 140 | 688 | |
| Last Close Price | 1.15 | 1.74 | 1.83 | 6.12 | 18.72 | 59.88 | |
| PS Ratio | 1429.52 | 1829.48 | 303.38 | 167.33 | 37.93 | 591.53 | |
| PB Ratio | 3.29 | 4.96 | 0.96 | 1.19 | 1.75 | 2.63 | |
| P/TBV Ratio | 3.88 | 4.96 | 0.96 | 1.19 | 1.86 | 2.72 | |
| EV/Sales Ratio | 677.42 | 1205.35 | - | 1.86 | 13.62 | 387.68 | |
| Debt / Equity Ratio | 0.39 | 0.39 | 0.17 | 0.26 | 0.14 | 0.08 | |
| Net Debt / Equity Ratio | -2.04 | -2.04 | -1.20 | -0.98 | -0.99 | -0.92 | |
| Net Debt / EBITDA Ratio | 0.57 | 0.57 | 0.74 | 0.93 | 0.89 | 1.24 | |
| Net Debt / FCF Ratio | 0.55 | 0.55 | 0.79 | 0.92 | 1.02 | 1.70 | |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | |
| Quick Ratio | 1.34 | 1.34 | 2.70 | 3.47 | 2.73 | 6.23 | |
| Current Ratio | 1.40 | 1.40 | 2.77 | 3.60 | 3.25 | 6.82 | |
| Return on Equity (ROE) | -183.47% | -183.47% | -115.42% | -79.55% | -89.97% | -70.55% | |
| Return on Assets (ROA) | -57.88% | -57.88% | -49.45% | -30.50% | -37.53% | -36.35% | |
| Return on Capital Employed (ROCE) | -283.30% | -283.30% | -144.30% | -98.70% | -100.80% | -70.00% | |
| Earnings Yield | -90.94% | -71.06% | -162.35% | -97.05% | -71.89% | -28.93% | |
| FCF Yield | -95.19% | -74.38% | -158.28% | -89.56% | -55.80% | -20.66% | |
| Buyback Yield / Dilution | -72.63% | -72.63% | -22.49% | -11.51% | -14.27% | -34.62% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.